| ²é¿´: 10564 | »Ø¸´: 387 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
l1409358961
|
[É̼ҹ©Ó¦]
EGM-2ÅàÑø»ù-LONZAϸ°ûÅàÑø»ù
|
||
|
ÏÞÁ¿ x ÕÅ
Âú x ¿ÉʹÓã»ÓÐЧÆÚ x Ì죻¹ýÆÚ¿ÉÍË |
ÄÚÈÝ
![]() ²úÆ·Ãû³Æ£ºEGM-2ÅàÑø»ù lonza ²úÆ·¹æ¸ñ£ºkit CC-3162 EGM-2 BulletKit (CC-3156 & CC-4176) CC-3156 EBM-2 Basal Medium 500 ml CC-4176 EGM-2 SingleQuot Kit Suppl. & Growth Factors CC-3202 EGM-2 MV BulletKit (CC-3156 & CC-4147) CC-3156 EBM-2 Basal Medium 500 ml CC-4147 EGM-2 MV SingleQuot Kit Suppl. & Growth Factors Clonetics ® EGM®-2 Endothelial Cell Growth Medium-2 is an enhancement of EGM®Medium. BBE has been removed and there has been further optimization of the basal media. Final concentration of FBS is 2%. Clonetics® Media Products are specially designed to support the growth of human and animal primary derived cells. Media systems have been specifically developed and optimized for various cell systems. Media are supplied in several formats: Basal Medium- contains no growth factors cytokines, or supplements SingleQuots® Kit - growth factors, cytokines, and supplements BulletKit ® - basal medium and SingleQuots® Kit packaged together ±ÏÌØ²©ÉúÎïÌṩµÄ EGM-2ÅàÑø»ù LONZAÆ·ÅÆÐÔÄÜ׿Խ£¬²úÆ·EGM-2ÅàÑø»ù LONZA¹«Ë¾ÒÔÆäÓÅÐãµÄÆ·ÖÊ Âú×ãÄú²»Í¬ÊµÑéµÄ¶àÖÖÐèÇó¡£ ±ÏÌØ²©ÉúÎïÌṩµÄ EGM-2 MVÅàÑø»ùÐÔÄÜ׿Խ£¬²úÆ· EGM-2 MVÅàÑø»ù LONZA¹«Ë¾ÒÔÆäÓÅÐãµÄÆ·ÖÊÂú×ã Äú²»Í¬ÊµÑéµÄ¶àÖÖÐèÇó¡£ Ê¼ÓÚ1994ÄêµÄ±ÏÌØ²©ÉúÎ±ÏÁúת»ùÒòhttp://www.bilong.com£©ÓÚ1994Äê¾ÍÓëLONZA£¨ÔCambrex£©ºÏ×÷£¬Ò»Ö±±»ÊÚȨ´úÀíLonza²úÆ·£¬ÊÇÖйú´ó½µÚÒ»¼ÒLONZA´úÀíÉÌ£¬±ÏÌØ²©ÉúÎïÒ»Ö±ÓëLonza¹«Ë¾Ð¯ÊÖ¿ªÍØÖйúÊг¡¹«Ë¾£¬ÏÖÒѳÉΪÉúÎï¼¼ÊõÁìÓòµÄٮٮÕß,Ò²½«Lonza¹«Ë¾µÄÀíÄî¹á³¹µ½µ×£¬´òÔìÉúÎï¼¼ÊõиÅÄî¡£ »¶ÓÀ´µçǢ̸ѡ¹º£¬¸ü¶à²úÆ·ÇëµÇ¼www.bitebo.com ±±¾©±ÏÌØ²©ÉúÎï¼¼ÊõÓÐÏÞÔðÈι«Ë¾ http://www.bitebo.com 400ÈÈÏߣº400-833-9299 µç»°£º010-82015225 13366202681 ÕÅîÚ QQ£º1050524889 ´« Õæ£º010-62015131 http://www.bitebo.com/a/gb2312/p ... 2011/0726/4576.html |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡
ÒѾÓÐ3È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÉêÇë»Ø¸åÑÓÆÚÒ»¸öÔ£¬±à¼Í¬ÒâÁË¡£µ«ÏµÍ³ÉϵÄʱ¼äû±ä£¬¸ø±à¼ÓÖдÓʼþÁË£¬Ã»»Ø¸´
ÒѾÓÐ4È˻ظ´
²ÄÁÏѧ˶318Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Öйúº£Ñó´óѧ£¬ÉúÎïѧ£¬301·Ö£¬Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
081700»¯¹¤Ñ§Ë¶µ÷¼Á
ÒѾÓÐ3È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
¡¾¼¼Êõ·þÎñ¡¿Ñо¿ËùºáÏò¼¼Êõ¿ª·¢¼°·þÎñ
+1/98
É¢½ð±Ò£¬Çó»ù½ðÖб꣡£¡
+1/84
ÖØÇìÒ½¿Æ´óѧÉñ¾¿ÆÑ§ÖÐÐÄ/²¡ÉúÓëÉúÀíϵ³ÏÑûº£ÄÚÍâÓÅÐ㲩ʿ¼ÓÃ˲©Ê¿ºó¶ÓÎ飨³¤ÆÚ£©
+1/81
É¢½ð±Ò£¬ÇóºÃÔË£¬×£ÃæÉÏ˳Àû£¡
+2/76
ÖйúÒ©¿Æ´óѧ211-¿ÎÌâ×éÕÐÊÕ2026²©Ê¿/˶ʿ
+1/53
¸£½¨Ê¦·¶´óѧÃö½Ñ§Õß³ÂΡ½ÌÊÚÍŶÓÕÐÊÕ2026Ä껯ѧ¡¢»¯¹¤»ò²ÄÁÏרҵµÄѧ˶6Ãû
+1/38
ºþÄÏ´óѧ΢ÉúÎï½á¹¹Ó빦ÄÜʵÑéÊÒ2026Äê¼Æ»®ÕÐÊÕ²©Ê¿Ñо¿Éú
+1/20
ÖÐɽ´óѧԺʿÍŶÓ΢ÄÉÆ÷¼þ¡¢ÄÔ»ú½Ó¿Ú·½Ïò²©Ê¿ÕÐÉú¡¢²©ºóÕÐÆ¸
+1/19
Î÷ÄÏij211ÕÐ27½ì²©Ê¿
+1/16
¡¾2026¿¼Ñе÷¼Á¡¿ÄÏ·½¿Æ¼¼´óѧ-ÉîÛÚÀí¹¤´óѧÁªÅà 086000 ÃâÒß·½Ïò(26.9Èëѧ)
+1/16
ÄϾ©ÁÖÒµ´óѧÓлú¹¦ÄÜ·Ö×ÓʵÑéÊÒ²©Ê¿ÉúÕÐÉúÆôÊÂ
+1/8
ÐÂ¼ÓÆÂ¹úÁ¢´óѧҩѧϵ»¯Ñ§ÉúÎïѧ¿ÎÌâ×éÕÐPhD
+1/8
ºÓÄÏ´óѧ¹¨ºÍ¹ó½ÌÊÚ2026Ä격ʿÑо¿ÉúÕÐÉú
+1/7
Ïã¸Û´óѧDavid Srolovitz½ÌÊÚ¿ÎÌâ×éÕÐÆ¸¡¸Ïã½Ñ§Õß¡¹²©Ê¿ºó
+1/6
ÕÐÊÕ»¯¹¤Óë²ÄÁÏѧ¿ÆµãÑо¿Éú
+1/4
Î人·ÄÖ¯´óѧ½ÜÇàÍŶÓÕÐÑо¿Éú£¨²ÄÁÏ£¬»¯Ñ§£¬¸ß·Ö×Ó£¬»¯¹¤£©
+1/4
º£ÍⲩʿÕÐÆ¸
+1/4
²©ºó¼´½«³öÕ¾£¬ÇóÎȶ¨µÄ½ÌÖ°
+1/3
±±¾©¸ßУ¸±Ð£³¤ÍŶÓÕÐÊÕ»úеÀ࣬»·¾³Ààѧ˶ºÍר˶
+1/2
ÖÐɽ´óѧҽѧԺÕÔ²©¿ÎÌâ×é˶ʿÕÐÉú
+1/1
|
¶¥ [ ·¢×ÔСľ³æ¿Í»§¶Ë ] |
164Â¥2015-04-16 07:20:54
¡ï
l1409358961(½ð±Ò+1): лл²ÎÓë
l1409358961(½ð±Ò+1): лл²ÎÓë
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
3Â¥2015-03-20 08:50:06

ÒÑÈëפСľ³æ



»Ø¸´´ËÂ¥